Patents by Inventor Ron Burke

Ron Burke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peritoneal dialysis solutions with polypeptides
    Patent number: 6730660
    Abstract: The present invention provides an improved dialysis solution. The improved dialysis solution provides for the use of specific polypeptides as an osmotic agent with an additional osmotic agent such as dextrose. To this end, the present invention provides, in an embodiment, a peritoneal dialysis solution comprising as osmotic agents approximately 0.25 to about 4.0% (w/v) polypeptides and approximately 0.5% to about 4.0% (w/v) dextrose. The polypeptides have well defined characteristics.
    Type: Grant
    Filed: July 20, 2001
    Date of Patent: May 4, 2004
    Assignee: Baxter International Inc.
    Inventors: Leo Martis, Ron Burke, Dirk Faict
  • Peritoneal dialysis solutions with polypeptides
    Patent number: 6380163
    Abstract: The present invention provides an improved dialysis solution. The improved dialysis solution provides for the use of specific polypeptides as an osmotic agent with an additional osmotic agent such as dextrose. To this end, the present invention provides, in an embodiment, a peritoneal dialysis solution comprising as osmotic agents approximately 0.25 to about 4.0% (w/v) polypeptides and approximately 0.5% to about 4.0% (w/v) dextrose. The polypeptides have well defined characteristics.
    Type: Grant
    Filed: December 22, 1992
    Date of Patent: April 30, 2002
    Assignee: Baxter International Inc.
    Inventors: Leo Martis, Ron Burke, Dirk Faict
  • Peritoneal dialysis solutions with polypeptides
    Publication number: 20010056062
    Abstract: The present invention provides an improved dialysis solution. The improved dialysis solution provides for the use of specific polypeptides as an osmotic agent with an additional osmotic agent such as dextrose. To this end, the present invention provides, in an embodiment, a peritoneal dialysis solution comprising as osmotic agents approximately 0.25 to about 4.0% (w/v) polypeptides and approximately 0.5% to about 4.0% (w/v) dextrose. The polypeptides have well defined characteristics.
    Type: Application
    Filed: July 20, 2001
    Publication date: December 27, 2001
    Inventors: Leo Martis, Ron Burke, Dirk Faict
  • Peritoneal dialysis solutions containing maltodextrins and amino acids
    Patent number: 6306836
    Abstract: A peritoneal dialysis solution comprising as osmotic agents approximately 2.0 to about 6.0% (w/v) maltodextrins and approximately 0.25 to about 2.0% (w/v) amino acids. The peritoneal dialysis solution will also include other components such as sodium, chloride, lactate, bicarbonate, calcium, and magnesium.
    Type: Grant
    Filed: January 21, 1994
    Date of Patent: October 23, 2001
    Assignee: Baxter International Inc.
    Inventors: Leo Martis, Ron Burke, Ty Shockley, Lee W. Henderson, Bernadette Faller